The primary clinical manifestation of Cryptococcus neoformans infectio
n in humans is meningoencephalitis. To study the defense mechanisms th
at participate in the host response against C. neoformans infection of
the central nervous system (CNS), we have developed a new model of cr
yptococcal meningitis in rats. Intracisternal inoculation of C. neofor
mans produced a granulomatous meningitis with minimal brain parenchyma
l involvement, resembling cryptococcal meningitis in immunocompetent p
atients. The granulomas were composed of T cells (CD4(+) and CD8(+)) a
nd macrophages (CD11b/c(+)); a subpopulation of the macrophages expres
sed inducible nitric oxide synthase (NOS2). In this model, C. neoforma
ns disseminated to systemic organs early in the course of infection an
d provoked granuloma formation and NOS2 expression. The temporal profi
le of inflammation indicated that the CNS inflammatory response is del
ayed relative to that in the lung and the spleen, which suggests that
the effective inflammatory response within the CNS may follow activati
on of T cells in the periphery and their subsequent entry into the CNS
. Inflammation in the meninges was associated with signs of subpial an
d subependymal glial activation, including enhanced expression of CD11
b/c and CD4 in microglia and glial fibrillary acidic protein in astroc
ytes. Neither cells, however, expressed NOS2. Although C. neoformans i
nvasion to the brain parenchyma was rare, soluble polysaccharide was c
ommonly associated with reactive glial cells. Necrosis was not a featu
re of C. neoformans granulomas, but, instead, inflammatory cells under
went apoptosis in inflamed organs. The current rat intrathecal cryptoc
occosis model has several unique advantages for the study of human cry
ptococcal meningoencephalitis that include close resemblance of histop
athologic changes to those in humans, easy accessibility to the cerebr
ospinal fluid compartment, and no requirement of immunosuppressive age
nts for establishment of infection.